MENU CLOSE
About Us

Who We Are

Our Social Responsibility

Events

Exhibitions

Activeties

Members

Hospitals

Individuals

Companies

Member Benefits

 
Bio-medical projectsi

State Key Laboratory of Biotherapy

Cooperation

Achievement Exhibition

Scimea Journals

Signal Transduction and Targeted Therapy

News

News Information

 
Home   >  News
14 Aug 2020
730
Molecular Biomedicine | Progress in exosome associated tumor markers and their detection methods
Scimea

In recent years, the tumor-derived exosome has been perceived as a hot and emerging biomarker for various cancers diagnosis and management in non-invasive manner. However, the problem of exosome isolation and detection hinder the application of exosomes. In the review newly published by Molecular Biomedicine, authors summarized the recent progress on exosome associated tumor biomarkers and some new technologies for exosome isolation and detection and also discussed future direction of exosome analysis methods.

 

 

1598495402(1).png


Exosomes are secreted by cells and are widely present in body fluids. Exosomes contain various molecular constituents of their cells of origin such as proteins, mRNA, miRNAs, DNA, lipid and glycans which are very similar as the content in tumor cells. These contents play an important role in various stages of tumor development, and make the tumor-derived exosome as a hot and emerging biomarker for various cancers diagnosis and management in non-invasive manner. The present problems of exosome isolation and detection hinder the application of exosomes. With the development of exosome isolation and detection technology, the contents of exosomes can be exploited for early cancer diagnosis. This review summarizes the recent progress on exosome associated tumor biomarkers and some new technologies for exosome isolation and detection, including viscoelasticity-based microfluidic system (Fig. 1), acoustofluidics-based isolation method (Fig. 2) etc. Furthermore, the future development direction in exosome analysis methods is also discussed.

 

 

Fig. 1.png


Fig. 1 The microfluidic chip for exosome separation from large EVs

 




 

 

Fig. 2.png 


Fig. 2 The platform underlying integrated acoustofluidic device for isolating exosomes

 

 

 

 

 

 

Article Access: https://link.springer.com/article/10.1186/s43556-020-00002-3

 

 


                                                                                                                   

Website for Molecular Biomedicine: https://www.springer.com/journal/43556

Looking forward to your contributions


MedComm | Vitamin intervention for cytokine storm in the patients with coronavirus disease 2019
Professional Committee of Anesthesiology of SCIMEA Formally Established
3nd Notice on 2019 China-Japan Advanced Medical and New Drug R&D Summit Forum & Achievements Transformation Conference
The Expansion Meeting of the Orthopedics Special Committee of Sichuan International Medical Exchange & Promotion Association Successfully Held
MedComm | Modelling t(8;21) acute myeloid leukaemia ‐ What have we learned?
Latest Events Journals News Members About Us Home
Contact Us

Address: No. 1103-1105, Building 6, S2, Global Center, High-tech Zone, Chengdu

Email: scimea@163.com 

Tel: (0086-)028-63859818   

Fax: (0086-)028-63859818   

Contact: (0086-)19113901604 (wechat:19113901604)


Follow Us
Copyright © 2009-2019 SCIMEA. All rights reserved 蜀ICP备19011649号-1